The spray dryer can be disassembled for autoclave sterilization and works to produce small-scale samples with minimum product loss.
Fluid Air introduced the PolarDry Electrostatic Spray Dryer, Model 0.1, its newest spray dry and microencapsulation product for feasibility testing.
According to a company press release, the spray dryer can be disassembled for autoclave sterilization and works to produce small-scale samples with minimum product loss. Additionally, the small size of the spray dryer allows for it to fit inside most lab fume or containment hoods, where noxious solvents, potent APIs, and oxygen sensitive materials are tested, making the exploration of new products more efficient and cost-effective before full-scale testing.
Source: Fluid Air
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.